SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-21-016080
Filing Date
2021-03-17
Accepted
2021-03-17 16:28:31
Documents
17
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K f10k2020a1_intecpharma.htm   iXBRL 10-K/A 100498
2 CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANT (ISR.), INDEPENDEN f10k2020a1ex23-1_intec.htm EX-23.1 4870
3 CERTIFICATION f10k2020a1ex31-1_intec.htm EX-31.1 13236
4 CERTIFICATION f10k2020a1ex31-2_intec.htm EX-31.2 13245
5 GRAPHIC ex23-1_001.jpg GRAPHIC 3429
6 GRAPHIC ex23-1_002.jpg GRAPHIC 9239
  Complete submission text file 0001213900-21-016080.txt   366978

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ntec-20201231.xsd EX-101.SCH 3186
8 XBRL LABEL FILE ntec-20201231_lab.xml EX-101.LAB 34582
9 XBRL PRESENTATION FILE ntec-20201231_pre.xml EX-101.PRE 22707
10 EXTRACTED XBRL INSTANCE DOCUMENT f10k2020a1_intecpharma_htm.xml XML 6822
Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Filer) CIK: 0001638381 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37521 | Film No.: 21750910
SIC: 2834 Pharmaceutical Preparations